REFRACTORY MERKEL CELL CARCINOMA
Clinical trials for REFRACTORY MERKEL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MERKEL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested for Tough-to-Treat skin cancer
Disease control OngoingThis study is for people with advanced Merkel cell carcinoma, a rare and aggressive skin cancer, that has stopped responding to standard immunotherapy. It aims to see if adding a new drug called tuvusertib to an existing immunotherapy (avelumab) can help control the cancer for lo…
Matched conditions: REFRACTORY MERKEL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Virus + drug combo tested for Tough-to-Treat skin cancers
Disease control OngoingThis study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…
Matched conditions: REFRACTORY MERKEL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC